About

Provided by Berger Montague

Berger Montague’s nationally recognized Whistleblower, Qui Tam & False Claims Act Group has recovered More than $3 billion for federal and state governments, as well as over $500 million for our whistleblower clients.

Berger Montague’s award-winning team has litigated False Claims Act cases for over two decades. Berger lawyers Sherrie Savett, Joy Clairmont, Michael Fantini, and William Ellerbe won The Anti-Fraud Coalition’s Whistleblower Lawyers of the Year Award this year for their work on United States ex rel. Silver v. Omnicare, Inc., PharMerica Corp, et al. and United States et al. ex rel. Penelow v. Janssen Products, LP. Both were government-declined cases that Berger Montague doggedly litigated for over a decade. On March 28, 2025, the Court decided all post-trial motions, whereby it trebled damages, imposed civil penalties, and entered Final Judgment against Janssen for over $1.6 billion. The PharMerica case settled for over $100 million.

Few firms are willing to take the risk of fully litigating a qui tam case where the government has declined to intervene. Even fewer firms are willing to do so against large corporations. But we do. And we have a record of winning.

Read more about our practice at www.bergermontague.com/whistleblower.

Chambers Review

Provided by Chambers

False Claims Act: Plaintiff - USA - Nationwide

2
Band 2

What the Team is Known For

Berger Montague is strongly recognized for its FCA practice. The attorneys represent whistleblowers in qui tam actions and broader civil litigation matters. The team is active in the pharmaceutical, healthcare and life sciences spaces.

Notable practitioners

Joy Clairmont is a key contact at the firm.

Work Highlights

  • Berger Montague assisted whistleblower-relator clients in a FCA case brought against Janssen, relating to alleged illegal promotion of HIV-treatment drugs.

Strengths

Provided by Chambers